Loading company…
Boston-based PathAI develops AI-powered pathology software that helps pathologists identify diseases such as cancer more accurately.
Founded in 2016 in Boston, US, PathAI, Inc. is a biotechnology company that builds AI solutions for pathology, using machine learning to analyze slides and assist pathologists. Its customers include hospitals, clinical laboratories and biopharma companies, typically on multi-year subscription contracts. Andrew Beck is CEO. The company has raised USD 165 mn in total, including a Series C completed on May 19, 2021, with investors including D1 Capital Partners and Kaiser Permanente Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in